EU-GMP INSPECTION, 2013

On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued by European Medicines Agency, Germany (the “EMA“).

Since 6 years from the date the Factory II has been officially run the operation, the Factory II has continuously recognized as European standard pharmaceutical facility. This is the collective pride of its company’s employees and this proves that we maintain product quality inherent.

It was really a pleasure for us to maintain and observe the right to export the products to foreign markets such as Europe, England, Australia, etc. and some countries complying PIC Convention (Pharmaceutical Inspection Convention).

With this achievement, the company will  be increasingly relentless determination to improve our infrastructure, and investment in machinery, equipment, technology, and qualified personnel as well, etc. to produce and provide high-quality products for the domestic and export activities.

About STELLA

STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com

You May like

06 Mar 2025

VIỆT NAM BOOSTS PHARMACEUTICAL CHEMICAL EXPORTS

By 2030, Việt Nam aims to produce 20 per cent of the raw materials needed for pharmaceutical production, meeting 50 per cent of the demand for functional food and cosmeceutical ingredients domestically. HÀ NỘI — Deputy Prime Minister Lê Thành Long has signed a decision approving a programme to develop the domestic pharmaceutical chemical industry

05 Mar 2025

PHARMA TRADING LANDSCAPE UNDERGOING SIGNIFICANT SHIFT

The trade deal between Vietnam and the EU has been making significant impacts on the home pharma market, driven by tariff reductions, marketing simplifications, and clearer business rights. According to the latest statistics from Vietnam Customs, pharmaceutical imports totalled nearly $4.4 billion last year, up 27.9 per cent from 2023, of which $2.5 billion came